Zebrafish as a tool for the discovery of anticonvulsant compounds from botanical constituents
- 1 October 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 908, 174342
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (304450/2019-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (304450/2019-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (304450/2019-7)
This publication has 100 references indexed in Scilit:
- Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor versus Electrographic Responses to Antiepileptic DrugsPLOS ONE, 2013
- Standards for epidemiologic studies and surveillance of epilepsyEpilepsia, 2011
- Identification and Quantification of Coumarins in Peucedanum ostruthium (L.) Koch by HPLC-DAD and HPLC-DAD-MSJournal of Agricultural and Food Chemistry, 2011
- Spontaneous Seizures and Altered Gene Expression in GABA Signaling Pathways in amind bombMutant ZebrafishJournal of Neuroscience, 2010
- Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotypeHuman Molecular Genetics, 2010
- Transgenic zebrafish models of neurodegenerative diseasesBrain Structure and Function, 2010
- Complementary and alternative medical therapiesCurrent Opinion in Neurology, 2008
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Learning from Small Fry: The Zebrafish as a Genetic Model Organism for Aquaculture Fish SpeciesMarine Biotechnology, 2006
- FROM ZEBRAFISH TO HUMAN: Modular Medical ModelsAnnual Review of Genomics and Human Genetics, 2002